FDA bans Hydroxycholoquine use in USA, but Yale expert (and many doctors) say it should be used early and asap

The most popular drug with doctors all over the world will seemingly now not even be allowed in the US for Covid related treatment: HCQ No Longer Approved Even a Little for COVID-19

Molly Walker, MedPage

The FDA rescinded its emergency use authorization (EUA) of hydroxychloroquine (HCQ) to treat COVID-19 patients, citing concerns about efficacy and risks associated with its use, and saying the drug no longer meets the criteria for an EUA, the agency said on Monday.

Moreover, the FDA now says the benefits of the drug “no longer outweigh the potential risks,” citing the serious cardiac adverse events associated with the drug.

Comments underneath reveal just how contested this will be.

It’s a strange situation where patients in many poorer nations are being offered drugs that patients won’t be able to get in the richest nation in the world:

Substantial fractions of physicians treating Covid-19 patients in Europe and elsewhere report use of HCQ+AZ: 72% in Spain, 49% in Italy, 41% in Brazil, 39% in Mexico, 28% in France, 23% in the US, 17% in Germany, 16% in Canada, 13% in the UK (45), much of the non-US use in outpatients.

[…]